Document Detail


Nutritional status affects long term survival after lobectomy for lung cancer.
MedLine Citation:
PMID:  17481775     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
STUDY OBJECTIVES: Nutritional status has been reported as a predictor of complications following surgery for lung cancer. However, the impact of impaired nutrition in the long term has not been extensively studied. We have analysed our own experience after lobectomy for non-small cell lung cancer (NSCLC). PATIENTS: Six hundred and forty-two consecutive patients undergoing lobectomy for primary lung cancer in a single centre between October 1991 and April 2004 were included in the study. STUDY DESIGN: Impaired nutritional status was defined as any of low pre-operative albumin level (less than 30g/L), recent history of weight loss or low body mass index (BMI)--less than 18.5kg/m(2). There were 400 males and 242 females, median age 66 (range 32-89 years). Outcomes studied were hospital mortality and complications, and long term survival. RESULTS: A high proportion of patients (185 of 642, 28%) were classed as having poor nutritional status. There were 12 hospital deaths (1.9%). Nutritional depletion had no significant impact on hospital mortality (1.3% versus 2.7%), cardiac (14.4% versus 16.8%), or respiratory (17.5% versus 18.9%) complications. The overall median survival was 48+/-6 months (standard error). On Cox multivariate analysis, impaired nutritional status, tumour stage and need for en bloc chest wall excision were all independent predictors of survival. CONCLUSIONS: Nutritional status does not appear to significantly influence immediate outcomes following lobectomy for lung cancer. However, it is a predictor of survival in the long term independently of tumour extension and staging.
Authors:
Nilanjana Tewari; Antonio E Martin-Ucar; Edward Black; Lynda Beggs; F David Beggs; John P Duffy; W Ellis Morgan
Related Documents :
19318995 - A landmark point analysis with cytotoxic agents for advanced nsclc.
18957625 - Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
11742695 - Angiogenesis and antiangiogenic agents in non-small cell lung cancer.
18096565 - Multicenter phase ii trial of gefitinib first-line therapy followed by chemotherapy in ...
8732695 - Treatment of oral cavity and oropharynx squamous cell carcinoma with perilymphatic inte...
14690165 - Therapeutic outcome of extranodal nk/t-cell lymphoma initially treated with chemotherap...
Publication Detail:
Type:  Journal Article     Date:  2007-05-03
Journal Detail:
Title:  Lung cancer (Amsterdam, Netherlands)     Volume:  57     ISSN:  0169-5002     ISO Abbreviation:  Lung Cancer     Publication Date:  2007 Sep 
Date Detail:
Created Date:  2007-08-27     Completed Date:  2007-12-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8800805     Medline TA:  Lung Cancer     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  389-94     Citation Subset:  IM    
Affiliation:
Department of Thoracic Surgery, Nottingham City Hospital, Hucknall Road, Nottingham NG5 1PB, United Kingdom. nilanjana_t@yahoo.co.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Female
Great Britain / epidemiology
Humans
Lung Neoplasms / mortality*,  pathology,  surgery*
Male
Middle Aged
Nutritional Status*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene ...
Next Document:  A measure of satisfaction with food-related life.